CATRIN Researchers from BioMed Group RCPTM Receive Best Poster Award at NanoBio 2025 Conference
Two researchers of BioMed group from Czech Advanced Technology and Research Institute (CATRIN) have attended recently international NanoBio 2025 Conference, held in September in Crete, Greece.
We are delighted to congratulate to Argiris Kolokithas Ntoukas, who has been awarded the Best Poster Award. His poster, entitled “Magnetic Nanoclusters for Alzheimer’s Disease Theranostics,” was recognized for its innovative approach, exploring how magnetic nanoclusters can open new possibilities for the treatment of Alzheimer.
The presented research focuses on the development of superparamagnetic nanoclusters as theranostics agents for the imaging and drug delivery of novel experimental drug substances for Alzheimer’s disease. A joint effort from scientists in CATRIN and research groups from IEM CAS (dr. Martin Horak, Department of Neurochemistry)) and University Hospital Hradec Kralove (prof. Ondrej Soukup, Biomedical Research Center) in the framework of OPJAK ExRegMed project (Excellence in Regenerative Medicine https://www.iem.cas.cz/en/research/research-projects/exregmed/ ) , represents a significant step forward and an example of innovation at the intersection of nanotechnology and medicine.
Dr. Sarka Hradilova has presented the poster titled: “In vitro cytotoxicity of thin-film neural probes based on reduced graphene oxide” where she introduced the newest important results that BioMEd group has achieved in framework of the prestigious European EIC Pathfinder project called MInigraph. https://minigraph-project.eu . The aim of the Minigraph project is to develop a next-generation neuroelectronic therapy based on graphene based microelectrodes with superior spatial resolution and long-term performance while maintaining optimal compatibility with brain tissue to meet critical needs in brain–computer interface technology.
“This Nanobio 2025 conference ( https://nanobioconf.com) gathers a lot of top experts and world class renowned scientists from the fields of nanotechnology and medicine, making it extremely interesting and an ideal place to discuss new ideas and share our research.” Said the group leader of BioMed group and PI of both mentioned projects, dr. Katerina Polakova.
This work was supported by the European Regional Development Fund under the project “Excellence in Regenerative Medicine” (No. CZ.02.01.01/00/22_008/0004562) and by the European Union’s Horizon Europe research and innovation program under grant agreement number 101070865 (MINIGRAPH).